|
AMLX Amylyx Pharmaceuticals Inc 1658551 |
| Balance Sheet |
|
Current Assets
|
189,432,000 |
|
Assets
|
193,634,000 |
|
Current Liabilities
|
28,406,000 |
|
Liabilities
|
28,869,000 |
|
Equity
|
164,765,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-167,647,000 |
|
Investing Cash Flow
|
75,654,000 |
| Market Analysis |
Market Cap
|
194,103,155 |
|
Price
|
3.71 |
|
BVPS
|
55.45 |
|
PB
|
0.07 |
|
PS
|
0.56 |
|
FCF
|
-91,993,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/22 |
0.07 |
3/4 |
-4.43 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AMLX documents filed with the SEC.
AMLX Filings
Clear
